Compare Giant Biogene Holding Co. Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- The company is Net-Debt Free
2
The company has declared negative results in Dec'2025 after 3 consecutive positive quarters
3
With ROE of 0.02%, it has a Very Expensive valuation with a 3.26 Price to Book Value
4
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.05%
0%
-17.05%
6 Months
-23.18%
0%
-23.18%
1 Year
-66.27%
0%
-66.27%
2 Years
-46.46%
0%
-46.46%
3 Years
-24.51%
0%
-24.51%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Giant Biogene Holding Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
22.36%
EBIT Growth (5y)
33.69%
EBIT to Interest (avg)
2.64
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.82
Sales to Capital Employed (avg)
11.53
Tax Ratio
37.90%
Dividend Payout Ratio
31.32%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
14330
Industry P/E
Price to Book Value
3.26
EV to EBIT
6684.80
EV to EBITDA
6265.73
EV to Capital Employed
65.70
EV to Sales
250.69
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.98%
ROE (Latest)
0.02%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
5,985.00
6,005.30
-0.34%
Operating Profit (PBDIT) excl Other Income
2,389.20
2,527.40
-5.47%
Interest
0.30
0.30
Exceptional Items
54.20
46.90
15.57%
Consolidate Net Profit
2,076.50
2,235.40
-7.11%
Operating Profit Margin (Excl OI)
384.30%
411.90%
-2.76%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -0.34% vs 54.21% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -7.11% vs 39.69% in Dec 2024
About Giant Biogene Holding Co. Ltd. 
Giant Biogene Holding Co. Ltd.
FMCG
No Details Available.
Company Coordinates 
No Company Details Available






